Sort
48,018 grants matching “immunotherapy”
Study interactions between lung microbiota and immune cells in NSCLC
$606,168Chen Zhao · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$606,001Javid J Moslehi · University Of California, San Francisco · R01 · FY2024 · HL
Stromal targeting to improve the efficacy of systemically administered drugs for pancreatic ductal adenocarcinomas
$605,990Luis Solorio · Purdue University · R01 · FY2025 · CA
Precision-based Assessment for the Detection of Mild Cognitive Impairment in Older Adults
$605,894Rosie E Curiel Cid · University Of Miami School Of Medicine · R01 · FY2019 · AG
Prebiotic effect of eicosapentaenoic acid treatment for colorectal cancer
$605,801Andrew T Chan · Massachusetts General Hospital · R01 · FY2022 · CA
In situ single cell imaging
$605,767Feng Gao · Dotquant, Llc · R44 · FY2020 · CA
In situ single cell imaging
$605,767Hong Yan Liu · Dotquant, Llc · R44 · FY2021 · CA
Systems analyses of induction and maintenance of immunity to SARS-CoV-2 vaccination in kidney transplant recipients receiving mycophenolate mofetil immunotherapy
$605,731Elaine F Reed · University Of California Los Angeles · U01 · FY2024 · AI
Development of selective HDAC6 inhibitors to improve cancer immunotherapy
$605,710Alejandro V Villagra · Georgetown University · R01 · FY2023 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$605,681John Tanner Wilson · Vanderbilt University · R01 · FY2022 · EB
Project 1: Physical modeling and dynamics of tumor cell migration mechanics
$605,631David J Odde · University Of Minnesota · U54 · FY2019 · CA
Developmental Funds
$605,554Thomas P Loughran · University Of Virginia · P30 · FY2017 · CA
Immune cell control of ovarian cancer
$605,550Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
COPD Clinical Research Network
$605,533University Of California San Francisco · U10 · FY2004 · HL
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
$605,520Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Normal and Pathologic Regulation of CTCF Target Sites by CTCF Like BORIS Factor
$605,512Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Cerebral amyloid angiopathy: Role of ApoE, innate immunity, and meningeal lymphatics
$605,486David M Holtzman · Washington University · P01 · FY2025 · AG
Personalized, antigen-directed immunotherapy delivered to lymph nodes
$605,458Eva M Sevick-Muraca · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$605,357Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · DE
Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis
$605,325Kevin Keewoun Kim · University Of Michigan At Ann Arbor · R01 · FY2025 · HL
Diabetic Neuropathy Study
$605,279Peter James Dyck · Mayo Clinic Rochester · R01 · FY2008 · NS
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$605,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$605,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Therapeutic approaches for LKB1-deficient non-small cell lung cancer
$605,252John V. Heymach · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$605,248Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK